Neuronetics, Inc.



The NeuroStar is a commercially available, FDA cleared, non-invasive, TMS treatment solution marketed for patients who suffer from severe depression. Launched in October of 2008, the NeuroStar has quickly been regarded a significant innovation in its industry for the success stories it has fostered. It has received numerous awards and patents as well as having been honored with a prestigious Gold/Medical Device Excellence Award.


  • Industrial Design
  • Product architecture
  • Component part design and engineering
  • Usability research, testing and HF documentation
  • Product graphics, marketing collateral
  • Device labeling